RecruitingNCT06827262
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Sponsor
Boston Scientific Corporation
Enrollment
1,500 participants
Start Date
Mar 26, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called Intracept™ Intraosseous Nerve Ablation for people with chronic low-back pain and vertebrogenic pain syndrome. The study is currently recruiting participants at 17 locations. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEIntracept™ Intraosseous Nerve Ablation
Intracept™ Intraosseous Nerve Ablation for treatment of patients diagnosed with vertebrogenic pain
Locations(18)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06827262
Related Trials
Psilocybin in Chronic Low Back Pain and Depression
NCT063554141 location
Improving Health for Patients With Chronic Low Back Pain in Rural Communities Through Telerehabilitation
NCT064719202 locations
Ultrasound-Guided Proximal Superior Cluneal Nerve Block for Superior Cluneal Nerve Entrapment
NCT077124061 location
Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
NCT071908077 locations
High-Intensity Laser Therapy Versus Transforaminal Epidural Steroid Injection in Chronic Lumbar Disc Herniation-Related Low Back and Radicular Pain
NCT076889151 location